Sudden deaths doubled after Covid shots, Pfizer trials show

During trials of its Covid vaccines, pharmaceutical giant Pfizer found that sudden deaths doubled after people had been injected with the mRNA injections.

Disturbing findings were revealed aa new analysis from the Pfizer trial data.

The researchers found that sudden deaths were twice as high in the original vaccine group Pfizer clinical trial compared with those who received a placebo.

The researchers behind the new analysis are now sounding the alarm about the safety of the new mRNA drug.

However, Pfizer has not made the data public and has been fighting in court to keep it sealed.

The dataof the original randomized controlled trial (RCT) of the vaccine, was released as part of a legal action in Texas.

Health Counseling and Recovery Team (HART) researchers Found four more sudden deaths in the vaccine group than in the placebo group.

All sudden deaths occurred after the first 60 days of being injected.

Many vaccine safety guarantees assume that any damage will be seen within 28 days of vaccination, meaning that signs would be lost after 60 days.

In total, there were 12 sudden deaths without an underlying cause: eight in the vaccine group and four in the placebo group.

Three occurred in each group during the first 60 days; subsequently, five occurred in the vaccine group, but only one in the placebo group.

Even more troubling, the researchers warn, is that these four additional sudden deaths in the vaccine group account for the entire difference in the total number of deaths between the two groups: 20 in the vaccine group versus 16 in the placebo group .

Conversely, the six reported Covid deaths in the placebo group did not lead to an excess of non-sudden deaths in the placebo group, as there were 12 non-sudden deaths in each group.

This suggests that while the vaccine did not prevent non-sudden deaths from causes such as Covid, it did cause sudden deaths.

However, while these trial numbers are clearly a red flag that urgently requires further investigation, the relatively small numbers involved mean that the results are not statistically significant.

Statistically speaking, we cannot be more than 95% sure that they did not occur by chance.

This despite the trial in which 44,000 people participated.

If this death rate were to occur in the entire population, it would equate to a vaccine death rate of about one in 5,000 people.

This signal should not be ignored, even if it falls below the significance threshold in this assay.

What it indicates is the need for further investigation to confirm or rule out the risk.

The researchers note that the six deaths from Covid in the placebo group represent 38% of the 16 total deaths in this group.

The figure is an extraordinarily high proportion that calls into question how Covid deaths were identified.

The HART researchers also found evidence of potential bias in what was supposed to be a blinded trial.

The median time to report deaths in the vaccine group was two to three times longer than in the placebo group.

Tellingly, perhaps, the longest delays in reporting deaths in vaccine groups occurred before the critical interim report on which the vaccine’s emergency approval was based.

In that period, deaths in the vaccine group took an incredible 18 days on average to be reported, while deaths in the placebo group in the same period took just five days.

Mysteriously, reports of deaths in the vaccine group took up to seven days on average, once the key interim data deadline passed.

The HART team also drew attention to questionable classification decisions.

An example was a 65-year-old man from Texas whose death 11 days after receiving a Covid vaccine was classified as unvaccinated.

He was marked as unvaccinated because, after unblinding, he had received the Moderna vaccine.

Because many of these apparent biases favor the vaccine, any estimate of harm should be understood as a lower bound.

Sudden deaths twice as high in the vaccine group as in the placebo group in a clinical trial should have raised alarm bells among regulators early on.

The fact that it doesn’t just adds to the wider scandal surrounding these experimental injections.

READ MORE: Top cardiologist testifies: Covid shots ‘not safe for human use’